U.S. Unveils “One Health” Framework to Address Global Health Governance and Surveillance Concerns

The U.S. has taken a significant step by launching the “One Health” framework, a strategy aimed at tackling diseases that jump from animals to humans. This initiative, driven by the CDC, USDA, and DOI, is designed to enhance public health readiness against threats like COVID-19, mpox, bird flu, and Ebola. The introduction of this framework marks a notable effort to address health challenges that stem from our interconnected world.

The National One Health Framework outlines seven principal objectives, including the surveillance of pathogens, pandemic readiness, and ensuring the safety of biolabs. It also puts an emphasis on understanding the environmental and social factors affecting health, such as climate change and land use. Furthermore, these principles are set to be incorporated into educational curriculums to better prepare future generations.

While supporters of the framework argue that it is a crucial step in addressing complex health threats, critics express concerns over its execution. Sayer Ji, the founder of GreenMedInfo, points out that the framework misses the mark by not focusing on essential health strategies.

He states, *“The lack of focus on regenerative agriculture, toxin reduction and lifestyle medicine demonstrates a troubling detachment from what truly promotes health at the individual and societal levels.”*

This initiative has ignited a debate regarding its impact on national sovereignty and the autonomy of individuals. Some critics see it as aligning with globalist agendas, akin to the WHO’s proposed Pandemic Treaty, which aims to centralize health decisions at an international level.

Dr. Meryl Nass, from Door to Freedom, suggests that the framework might bypass traditional public health policymaking. She notes, *“The plan is aimed at further embedding the extremely fuzzy concept of One Health into all government agencies, creating new interagency structures and mechanisms for decision-making outside the usual chain of command structures.”*

Ji shares these concerns, cautioning that the framework could lead to governance driven by crises. He warns, *“By focusing on zoonotic diseases, the framework risks entrenching centralized global systems that bypass democratic oversight.”*

The roots of this framework can be traced back to the 2023 Consolidated Appropriations Act, which called for federal agencies to focus on zoonotic diseases and be ready for pandemics. Critics feel that this, along with international initiatives like the WHO’s Pandemic Treaty, could threaten national control over health policies.

A major aspect of the One Health framework is its focus on disease surveillance and the development of vaccines. The plan seeks to monitor zoonotic diseases and their environmental causes while accelerating the advancement of diagnostics, vaccines, and therapeutics. However, some experts caution that this approach might prioritize biosecurity over comprehensive health solutions. Ji mentions, *“The framework’s focus on pathogen surveillance and vaccine development reflects a reactive, rather than proactive, approach to health.”*

The framework also ties One Health to issues of environmental justice and climate change, suggesting these should be integrated into public health strategies. Critics, however, argue that this broad scope might lead to government oversight extending into many areas of life.

As the U.S. framework aligns with global efforts to expedite drug approvals and pandemic responses, the U.K.’s Medicines and Healthcare Products Regulatory Agency is weighing a plan to fast-track drugs approved by “trusted” regulators elsewhere, which has sparked safety concerns.

Dr. Nass warns that such moves could trigger a “race to the bottom” regarding drug safety standards, remarking, *“By saying that any friendly nation’s drug regulator decision can stand in your country, that obviously will turn into a race to the bottom.”*

Barbara Loe Fisher, from the National Vaccine Information Center, has highlighted the risks of such expedited approvals, noting her observations over the past four decades regarding the lowering of safety and efficacy standards by Congress.

These developments are part of a larger trend favoring global health governance. The Biden administration’s National Biodefense Strategy, aimed at developing vaccines within 130 days during health emergencies, has also met with criticism.

Brian Hooker, Ph.D., of Children’s Health Defense, warns that such aggressive timelines could jeopardize safety, stating, *“The whole prospect of rolling out a vaccine in 130 days is completely unrealistic and too many corners will be cut.”*

The One Health framework signifies a major shift in how the U.S. approaches public health, emphasizing cross-sector collaboration. However, the success of this initiative will likely hinge on maintaining a balance between crisis preparedness and democratic oversight, ensuring individual freedoms are respected.

Ji suggests that if the One Health concept acknowledges health as a product of balanced ecosystems, it could be beneficial. He states, *“But it must overcome the globalist push to centralize health decision-making under unelected bodies.”*

As global health governance initiatives gain traction, the discussion surrounding the One Health framework highlights a critical tension between preparedness and freedom. This ongoing debate will likely influence the future landscape of public health in the U.S. and globally.